ICH accounts for approximately 15 percent of all strokes. Despite improvements in neurocritical care, the mortality for patients with ICH can still reach 50 percent at 1-year, with many left with significant residual deficits. Patients with an ICH who are taking an oral anticoagulant medication tend to have larger ICH volumes, more frequent IVH, and a greater frequency of hematoma expansion. In this podcast, we review the latest recommendations on reversing anticoagulant medications in patients with an ICH. This is information you can’t afford to miss!
These are some of the sickest patients you’ll see in the ED and ICU. In this episode, we discuss incredibly useful pearls and pitfalls...
In December 2019 a novel coronavirus (now named COVID-19) was identified as responsible for a cluster of pneumonia cases in Wuhan, China. As of...
There has been an explosion of literature on the evaluation and management of patients with COVID-19 infection. In this podcast, we discuss updates (as...